The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan-Reference-Cited by-同舟云学术

The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan

Published:2014-04-29 Issue:1 Volume:14 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Katano Harutaka,Hishima Tsunekazu,Mochizuki Makoto,Kodama Yoshinori,Oyaizu Naoki,Ota Yasunori,Mine Sohtaro,Igari Toru,Ajisawa Atsushi,Teruya Katsuji,Tanuma Junko,Kikuchi Yoshimi,Uehira Tomoko,Shirasaka Takuma,Koibuchi Tomohiko,Iwamoto Aikichi,Oka Shinichi,Hasegawa Hideki,Okada Seiji,Yasuoka Akira

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/1471-2334-14-229.pdf

Reference31 articles.

1. Bruno R, Sacchi P, Filice G: Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy. AIDS. 2003, 17 (Suppl 1): S83-S87.

2. Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Munoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, et al: The Incidence of AIDS-Defining Illnesses at a Current CD4 Count > =200 Cells/μL in the Post-Combination Antiretroviral Therapy Era. Clin Infect Dis. 2013, 57: 1038-1047. 10.1093/cid/cit423.

3. Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD: AIDS across Europe, 1994–98: the EuroSIDA study. Lancet. 2000, 356: 291-296. 10.1016/S0140-6736(00)02504-6.

4. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998, 338: 853-860. 10.1056/NEJM199803263381301.

5. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ. 1997, 315: 1194-1199. 10.1136/bmj.315.7117.1194.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Chimeric Antibody against the HIV-1 Fusion Inhibitory Peptide MT-C34 with a High Affinity and Fc-Mediated Cellular Cytotoxicity;Biology;2024-08-29

2. INTERDISCIPLINARY IN MANAGING HIV/AIDS INFECTED PATIENTS – THE IMPORTANCE OF TEAMWORK;Revista Medico-Chirurgicala;2022-12-30

3. Quantifying Deaths from Aspergillosis in HIV Positive People;Journal of Fungi;2022-10-27

4. Cytopathological analysis of bronchoalveolar lavage fluid in patients with and without HIV infection;BMC Pulmonary Medicine;2022-02-08

5. A case of AIDS-associated Kaposi’s sarcoma occurring in the oral cavity and systemic lymph nodes;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2021-12